The Zhitong Finance App learned that Lizhu Pharmaceutical (01513) rose more than 5% at the end of the session. As of press release, it rose 4.95% to HK$23.32, with a turnover of HK$35.1731 million.

According to the news, Livzon Pharmaceuticals announced results. Revenue for the first three quarters was 7.319 billion yuan, down 19.71% year on year; net profit to mother was 1,288 billion yuan, down 26.57% year on year. CICC said that the company's results for the first three quarters were in line with market expectations, and revenue and net profit for the third quarter improved month-on-month. In the third quarter of a single quarter, the company's revenue increased 8.97% month-on-month, net profit to mother increased 0.17% month-on-month, and net profit after deducting non-return to mother increased 18.82% month-on-month.

It is worth noting that Livzon Pharmaceuticals plans to distribute a cash dividend of 12.39 yuan (tax included) to all shareholders for every 10 shares, with an estimated total cash dividend of 1100 billion yuan. The company also formulated a shareholder return plan for the next three years, making it clear that under the conditions of cash dividends, the total amount of annual cash dividends is in principle not less than 90% of the distributable profits achieved in the current year, and the total amount of cash dividends distributed each year is not less than RMB 2 billion (tax included) in principle.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.